Nothing Special   »   [go: up one dir, main page]

PL322529A1 - Complex compositions containing benazeoprile or benazeprilate and valsartan - Google Patents

Complex compositions containing benazeoprile or benazeprilate and valsartan

Info

Publication number
PL322529A1
PL322529A1 PL96322529A PL32252996A PL322529A1 PL 322529 A1 PL322529 A1 PL 322529A1 PL 96322529 A PL96322529 A PL 96322529A PL 32252996 A PL32252996 A PL 32252996A PL 322529 A1 PL322529 A1 PL 322529A1
Authority
PL
Poland
Prior art keywords
benazeoprile
benazeprilate
valsartan
compositions containing
complex compositions
Prior art date
Application number
PL96322529A
Other languages
English (en)
Inventor
Gasparo Marc De
Randy Lee Webb
David Saul Cohen
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PL322529A1 publication Critical patent/PL322529A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL96322529A 1995-04-07 1996-04-02 Complex compositions containing benazeoprile or benazeprilate and valsartan PL322529A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (en) 1995-04-07 1996-04-02 Combination compositions containing benazepril or benazeprilat and valsartan

Publications (1)

Publication Number Publication Date
PL322529A1 true PL322529A1 (en) 1998-02-02

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96322529A PL322529A1 (en) 1995-04-07 1996-04-02 Complex compositions containing benazeoprile or benazeprilate and valsartan

Country Status (15)

Country Link
EP (1) EP0820302A1 (ja)
JP (1) JPH11503139A (ja)
KR (1) KR19980703647A (ja)
CN (1) CN1181019A (ja)
AU (1) AU5399096A (ja)
BR (1) BR9604818A (ja)
CA (1) CA2214143A1 (ja)
CZ (1) CZ313897A3 (ja)
HU (1) HUP9801593A2 (ja)
MX (1) MX9707683A (ja)
NO (1) NO974400D0 (ja)
PL (1) PL322529A1 (ja)
SK (1) SK133897A3 (ja)
TR (1) TR199701121T1 (ja)
WO (1) WO1996031234A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0835106A4 (en) * 1995-06-30 1998-09-30 Merck & Co Inc METHOD FOR TREATING KIDNEY DISEASES USING AN ACE INHIBITOR AND AII ANTAGONIST
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
MXPA02010090A (es) * 2000-04-12 2003-02-12 Novartis Ag Combinacion de al menos dos compuestos seleccionados de los grupos de un antagonista del receptor at-1 o un inhibidor ace o un inhibidor de la hmg-co-a reductasa.
AU2001289672B2 (en) * 2000-07-19 2005-12-08 Novartis Ag Valsartan salts
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
HUP0303836A2 (hu) * 2000-08-22 2004-04-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Angiotenzin antagonisták és ACE inhibitorok gyógyszerészeti kombinációja és ezeket tartalmazó gyógyszerkészítmények
CA2432638A1 (en) * 2000-12-18 2002-06-27 Novartis Ag Therapeutic combination of amlodipine and benazepril
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (zh) * 2002-07-05 2008-04-02 安徽省生物医学研究所 一种预测acei类降压药药效的复方药
US20050272649A1 (en) * 2002-08-28 2005-12-08 Hruska Keith A Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
SG176585A1 (en) 2009-05-20 2012-01-30 Boehringer Ingelheim Vetmed Pharmaceutical oral telmisartan solution
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
CN105939728A (zh) * 2014-01-31 2016-09-14 詹森药业有限公司 用于治疗和预防肾病和脂肪肝病的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0527879T3 (da) * 1990-05-11 1997-07-14 Pfizer Synergistiske terapeutiske præparater og fremgangsmåder.
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists

Also Published As

Publication number Publication date
NO974400L (no) 1997-09-23
CZ313897A3 (cs) 1998-01-14
KR19980703647A (ko) 1998-12-05
EP0820302A1 (en) 1998-01-28
CA2214143A1 (en) 1996-10-10
BR9604818A (pt) 1998-06-09
TR199701121T1 (xx) 1998-03-21
MX9707683A (es) 1997-12-31
JPH11503139A (ja) 1999-03-23
SK133897A3 (en) 1998-02-04
CN1181019A (zh) 1998-05-06
NO974400D0 (no) 1997-09-23
WO1996031234A1 (en) 1996-10-10
HUP9801593A2 (hu) 1999-01-28
AU5399096A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
GB2298422B (en) Compounds and their use
IL118825A0 (en) 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use
IL119864A0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
ZA965857B (en) Cable-sheathing composition
IL117859A0 (en) Isothiazolones and their uses
IL117294A (en) Organosilicon compounds and compositions containing them
SG52651A1 (en) Composition
ZA9684B (en) Composition and use
PL322571A1 (en) Deodoising composition
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
GB9518033D0 (en) Composition
IL117981A0 (en) Compositions containing 2-oxetanones their preparation and use
PL322529A1 (en) Complex compositions containing benazeoprile or benazeprilate and valsartan
HUP9600352A2 (en) Bitumenous composition
PL331423A1 (en) Muporocin and chlorohexidrin containing compositions
IL116015A0 (en) Iminooxymethyleneanilides thdir preparation and compositions containing them
HUP9802997A3 (en) Antisudorific and/or deodorant compositions
IL112564A0 (en) 1-beta-methyl-carbapenems and compositions containing them
HU9402155D0 (en) Azin-derivatives and insekticidal composition containing them
GB9508323D0 (en) Composition
IL113542A0 (en) Substituted hydroxybenzyl-heteroaryl derivatives compositions containing them and their use
GB9609515D0 (en) Powder composition
IL118547A0 (en) Aqueous film-formimg compositions and their use
EP0757075A3 (en) Polyaminotriazine composition
IL117155A0 (en) Quinolizinone derivatives and pharmaceutical compositions containing the same